Clinical predictors of acute response with quetiapine in psychotic mood disorders

Journal of Clinical Psychiatry

Volumn 61, Issue 3, 2000, Pages 185-189

  Zarate, Carlos A ^a   Rothschild, Anthony ^a   Fletcher, Kenneth E ^a   Madrid, Alex ^b   Zapatel, Jorge ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; AFFECTIVE NEUROSIS; AKATHISIA; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DYSPEPSIA; FEMALE; HEADACHE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; RECEPTOR AFFINITY; SCHIZOPHRENIA; TREMOR; VERTIGO;

EID: 0343729323     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0307     Document Type: Article

References (18)

1. Tohen M, Zarate CA Jr. Antipsychotic agents and bipolar disorder. J Clin Psychiatry 1998;59(suppl 1):38-48
2. McElroy SL, Dessain EC, Pope HG Jr, et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-414
3. Suppes T, McElroy S, Gilbert J, et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992;32:270-280
4. Banov MD, Zarate CA Jr, Tohen M, et al. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994;55:295-300
5. Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996;153:759-764
6. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995;56:411-417
7. Hillert A, Maier W, Wetzel H, et al. Risperidone in the treatment of affective disorders with a combined psychotic and depressive syndrome: a functional approach. Pharmacopsychiatry 1992;25:213-217
8. Tohen M, Zarate CA Jr, Centorrino F, et al. Risperidone in the treatment of mania. J Clin Psychiatry 1996;57:249-253
9. Keck PE Jr, Wilson DR, Strakowski SM, et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995;56:466-470
10. Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998;21:176-180
11. Tohen M, Sanger TM, McElroy SL, et al. Olanzapine vs placebo in the treatment of acute mania. Am J Psychiatry 1999;156:702-709
12. Zarate CA Jr, Narendran R, Tohen M, et al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 1998;59:24-28
13. Rothschild AJ, Bates KS, Boehringer KL, et al. Olanzapine response in psychotic depression. J Clin Psychiatry 1999;60:116-118
14. Arvanitis LA, Miller BG, and the Seroquel Trial 13 Study Group. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 1997;42:233-246
15. Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry 1997;54:549-557
16. Richelsen E. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry 1996;57(suppl 11):4-11
17. Mullen J, Reinstein M, Bari M, et al. Quetiapine and risperidone in outpatients with psychotic disorders: results of the QUEST trial [poster 163]. Presented at the 37th annual meeting of the American College of Neuropsychopharmacology; Dec 14-18, 1998; Las Croabas, Puerto Rico
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994